FDA Import Refusal AEK-8202286-2/11/1 — AbbVie Inc.
The FDA refused shipment AEK-8202286-2/11/1 from AbbVie Inc. (United States) on Jan 31, 2025. The refused product falls under Drugs and Biologics — RISANKIZUMAB-RZAA. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jan 31, 2025
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 58MCK09 RISANKIZUMAB-RZAA
- Charges
- 75